Goldman Sachs Group »

Atara Biotherapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Atara Biotherapeutics (ATRA) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $299k 582k 0.51
2023-09-30 $6.1M 4.1M 1.48
2023-06-30 $7.3M 4.6M 1.61
2023-03-31 $19M 6.7M 2.90
2022-12-31 $21M 6.2M 3.28
2022-06-30 $23M 2.9M 7.79
2022-03-31 $34M 3.6M 9.29
2021-12-31 $40M 2.6M 15.76
2021-09-30 $51M 2.9M 17.90
2021-03-31 $31M 2.1M 14.36
2020-12-31 $52M 2.6M 19.63
2020-09-30 $41M 3.2M 12.96
2020-06-30 $51M 3.5M 14.57
2019-12-31 $7.0M 423k 16.47
2019-09-30 $5.7M 402k 14.12
2019-06-30 $5.7M 284k 20.11
2019-03-31 $10M 259k 39.75
2018-12-31 $11M 324k 34.72
2018-09-30 $17M 410k 41.35
2018-06-30 $16M 422k 36.75
2018-03-31 $6.8M 173k 39.00
2017-12-31 $367k 20k 18.11
2017-09-30 $330k 20k 16.54
2017-06-30 $204k 15k 13.99
2017-03-31 $4.1M 201k 20.57
2016-12-31 $398k 28k 14.20
2016-09-30 $676k 32k 21.40
2016-06-30 $363k 16k 22.53
2015-09-30 $893k 28k 31.46
2014-12-31 $1.4M 53k 26.76